Mark Mulvahill

Mark Mulvahill is a founder of Stratix Labs and currently serves as its Chief Executive Officer. Mark has experience evaluating the commercial opportunity for new technologies and inventions. Prior to Stratix Labs, Mark founded Loewi LLC to develop intellectual property around novel drug delivery technologies. Loewi LLC assigned its IP portfolio to a commercial stage pharmaceutical company.

Mark is a Fulbright scholar in chemistry, Explorers Club grantee, and Fulbright-Hays grantee with a focus on antimicrobial drug discovery, as well as a registered patent agent with the USPTO (registration #78144). He earned an MBA from the Carlson School of Management University of Minnesota in 2017 with a specialization in healthcare. Mark earned a Master of Science degree in Chemistry from the University of the South Pacific in 2017 for research conducted during his Fulbright scholarship, and a Bachelor of Arts degree in Biology from the University of Denver in 2012. Mark currently serves as a Board Member of the UMN Medical Industry Leadership Institute Affiliates.